Literature DB >> 22299392

Lifestyle modifications after acute coronary syndromes in a subset of the AMI-Florence 2 Registry.

Francesco Sofi1, Alessia Fabbri, Rossella Marcucci, Anna Maria Gori, Daniela Balzi, Alessandro Barchielli, Giovanni Maria Santoro, Niccolo Marchionni, Rosanna Abbate, Gian Franco Gensini.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the adherence to recommendations for secondary prevention of cardiovascular diseases in patients with acute coronary syndromes (ACS). METHODS AND
RESULTS: Physical examination, a careful medical interview with assessment for lifestyle habits, adherence to pharmacological therapy and blood analyses were performed in 130 patients at the time of the acute event and after 6 months of follow-up. At follow-up examination, 7 patients persisted to smoke (5.4%), 41 (31.5%) continued to have high blood pressure, 34 (26.1%) had high levels of total cholesterol, 38 (29.2%) high levels of triglycerides, 64 (49.2%) high levels of LDL-cholesterol and 46 (35.4%) low levels of HDL-cholesterol. Despite all treatments no significant change occurred. A high percentage of patients (47%) reported a lower daily consumption of fruit and vegetables with respect to the recommended daily portions, nearly the whole population (92.3%) did not reach the recommended portions of legumes per week recommended, and a consistent percentage of patients (81.5%) did not consume fish twice a week, as recommended.
CONCLUSION: These findings demonstrate the difficulty of modifying the lifestyle habits in patients with ACS.

Entities:  

Mesh:

Year:  2011        PMID: 22299392     DOI: 10.1080/ac.66.6.2136965

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  1 in total

1.  Stability and change of lifestyle profiles in cardiovascular patients after their first acute coronary event.

Authors:  Patrizia Steca; Dario Monzani; Andrea Greco; Cristina Franzelli; Maria Elena Magrin; Massimo Miglioretti; Marcello Sarini; Marta Scrignaro; Luca Vecchio; Francesco Fattirolli; Marco D'Addario
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.